Although we focused on NLRP3 since it is activated in burn tissue and metabolic disease states (e.g., diabetes and obesity), we cannot exclude the fact that other NLRs could be involved and could compensate for inhibition of NLRP3 activation. The gene discussed is NLRP3; the disease is metabolic disease.